ArticleJournal of orthopaedic translation2026
Modular de- and re-construction of vascularized osteochondral tissues in an Organ-on-Chip dual-compartment platform.
Article in Journal of orthopaedic translation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Chondrogenic niche hydrogel microspheres facilitate cartilage regeneration in osteoarthritis.Bioactive materials · 2026Article
- Vascularized bone organoids: current advances and a biomimetic platform for osteonecrosis of the femoral head.Bone research · 2026Review
- Functional Biomaterials and 3D Bioprinting Approaches for Temporomandibular Joint Reconstruction: A Narrative Review.Journal of functional biomaterials · 2026Review
- Strategies for the Selection and Application of Biological Scaffolds in Organ-on-a-Chip Systems.Chembiochem : a European journal of chemical biology · 2026Review
- Advances in Bone-on-a-Chips for In Vitro Modeling of Bone Physiology and Pathology.Biomedicines · 2026Review
- Advancing the continuum of orthopaedic translation: Mechanistic insight, regenerative innovation, and converging technologies.Journal of orthopaedic translation · 2026Article
- Recent advances in organoids and organs-on-chips for accelerating orthopaedic innovation and translation.Journal of orthopaedic translation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Homeostasis at the cartilage-bone interface of articular joints depends on tightly orchestrated signalling among chondrocytes, osteogenic progenitors, and subchondral vasculature. Disruption of this crosstalk is considered one of the main drivers of osteoarthritis (OA), the most prevalent musculoskeletal disease worldwide. However, the timing, location, and mechanisms underlying the pathological onset of OA remain unclear, hindering the development of targeted regenerative strategies. This knowledge gap emphasises the need for Methods and results: Here, we present a modular, dual-compartment Organ-on-Chip (OoC) platform that enables the stepwise 'de- and re-construction' of the vascularized osteochondral unit, allowing systematic interrogation of cell-specific roles in homeostasis and inflammation. Through the side-by-side culture of human articular chondrocytes (hACs) and bone marrow-derived mesenchymal stromal cells (bmMSCs), we generated biphasic, compartmentalized constructs with a contiguous interface, in which bmMSCs exhibited osteogenic commitment without compromising the stable chondrogenic capacity of hACs. The addition of human umbilical vein endothelial cells (HUVECs) to the bmMSCs compartment at a finely tuned 3:2 ratio (bmMSCs:HUVECs) enabled the formation of lumenized vascular vessels surrounded by α-SMA-expressing cells and laminin sheaths, while preserving bmMSCs' osteogenic commitment. Under homeostatic conditions, the presence of a cartilage layer adjacent to such vascularized and mineralized tissue impeded vascular and stromal invasion, whereas exposure to IL-1β (1 ng/mL) allowed to override such chondrocyte "barrier," triggering endothelial and stromal penetration into the cartilage, thus mimicking inflammatory OA. Conclusion: The proposed platform combines ease of use, real-time imaging capabilities, and precise control over cellular modules, offering a versatile tool for future mechanistic studies in OA and related joint disorders. The translational potential of this article: This modular Organ-on-Chip platform offers a physiologically relevant and experimentally accessible model of the vascularized osteochondral interface, enabling systematic dissection of cell-specific roles in joint homeostasis and inflammation. By recapitulating key features of early osteoarthritic pathology-including barrier breakdown, stromal invasion, and endothelial remodeling- with a highly modular and technologically robust approach, this system holds translational promise for preclinical testing of disease-modifying OA therapies, biomarker discovery, and regenerative strategies targeting cartilage-bone crosstalk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.